EP0200225A2 - Culture d'un organe de catharanthus roseus capable de produire une quantité considérable d'alcaloides indoliques - Google Patents
Culture d'un organe de catharanthus roseus capable de produire une quantité considérable d'alcaloides indoliques Download PDFInfo
- Publication number
- EP0200225A2 EP0200225A2 EP86105971A EP86105971A EP0200225A2 EP 0200225 A2 EP0200225 A2 EP 0200225A2 EP 86105971 A EP86105971 A EP 86105971A EP 86105971 A EP86105971 A EP 86105971A EP 0200225 A2 EP0200225 A2 EP 0200225A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- culture
- alkaloids
- organ culture
- organ
- roseus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000000056 organ Anatomy 0.000 title claims abstract description 57
- 229930005303 indole alkaloid Natural products 0.000 title claims abstract description 17
- 150000002475 indoles Chemical class 0.000 title claims abstract description 16
- 240000001829 Catharanthus roseus Species 0.000 title claims description 22
- 229930013930 alkaloid Natural products 0.000 claims description 34
- GKWYINOZGDHWRA-UHFFFAOYSA-N catharanthine Natural products C1C(CC)(O)CC(CC2C(=O)OC)CN1CCC1=C2NC2=CC=CC=C12 GKWYINOZGDHWRA-UHFFFAOYSA-N 0.000 claims description 14
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 claims description 11
- 229960003048 vinblastine Drugs 0.000 claims description 11
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 229930195732 phytohormone Natural products 0.000 claims description 8
- WVTGEXAIVZDLCR-UHFFFAOYSA-N Vindoline Natural products CC1C2CN3CCCC14CCC5Nc6ccccc6C25C34 WVTGEXAIVZDLCR-UHFFFAOYSA-N 0.000 claims description 7
- CMKFQVZJOWHHDV-DYHNYNMBSA-N catharanthine Chemical compound C([C@@H]1C=C([C@@H]2[C@@]3(C1)C(=O)OC)CC)N2CCC1=C3NC2=CC=CC=C12 CMKFQVZJOWHHDV-DYHNYNMBSA-N 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 7
- CXBGOBGJHGGWIE-IYJDUVQVSA-N vindoline Chemical compound CN([C@H]1[C@](O)([C@@H]2OC(C)=O)C(=O)OC)C3=CC(OC)=CC=C3[C@]11CCN3CC=C[C@]2(CC)[C@@H]13 CXBGOBGJHGGWIE-IYJDUVQVSA-N 0.000 claims description 7
- CZJDUZOWQVAEEV-XIEZEKGWSA-N (+)-19-epi-Ajmalicine Natural products O=C(OC)C=1[C@@H]2[C@@H]([C@@H](C)OC=1)C[N+]1[C@H](c3[nH]c4c(c3CC1)cccc4)C2 CZJDUZOWQVAEEV-XIEZEKGWSA-N 0.000 claims description 6
- GRTOGORTSDXSFK-XJTZBENFSA-N ajmalicine Chemical compound C1=CC=C2C(CCN3C[C@@H]4[C@H](C)OC=C([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 GRTOGORTSDXSFK-XJTZBENFSA-N 0.000 claims description 6
- 229940007897 ajmalicine Drugs 0.000 claims description 6
- ZLQMRLSBXKQKMG-UHFFFAOYSA-N rauniticine Natural products COC(=O)C1=CC2CC3N(CCc4c3[nH]c5ccccc45)CC2C(C)O1 ZLQMRLSBXKQKMG-UHFFFAOYSA-N 0.000 claims description 6
- 229960004528 vincristine Drugs 0.000 claims description 5
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims description 5
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims description 5
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical group N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 description 22
- 206010020649 Hyperkeratosis Diseases 0.000 description 14
- 239000002609 medium Substances 0.000 description 12
- 230000002503 metabolic effect Effects 0.000 description 9
- 230000006698 induction Effects 0.000 description 7
- 230000012010 growth Effects 0.000 description 5
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 4
- 150000003797 alkaloid derivatives Chemical class 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003416 antiarrhythmic agent Substances 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 239000003617 indole-3-acetic acid Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229930192334 Auxin Natural products 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 1
- 229940012189 methyl orange Drugs 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 230000007174 organ induction Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S47/00—Plant husbandry
- Y10S47/03—Propagation of plant by cuttings
Definitions
- the invention relates to the production of indole alkaloids by cultivating organ culture of Catharanthus roseus (periwincle).
- C. roseus has been previously known to produce as secondary metabolic products various indole alkaloids useful as an antitumor, hypotensive or antiarrhythmic agent, and many attempts to produce and recover said alkaloids from the tissue culture of the plant have long been made.
- the applicant of the present application succeeded in preparing a callus from the plant and recovering the alkaloids from the callus (See Japanese Patent Application Ser. Nos. 85228/1982 and 197412/1982).
- such callus is not satisfactory as a stable supply source of the alkaloids because the alkaloid productivity of the callus is liable to gradually decrease due to the following reasons:
- an organ culture which starts from a particular organ of a plant, is generally recognized to retain secondary metabolic activity possessed by the parent plant.
- the organ culture is a culture system uniquely differentiated from a dedifferentiated or pre-differentiated tissue so as to develop a particular organ such as a stem, leaf, root or the like.
- the culture system thus obtained can be subcultured or massively cultured to produce various useful materials.
- the organ cultures of Papaver somniferum see T.Yoshikawa and T. Furuya, Planta Medica, 1985(2), 110-113
- Digitalis purpurea see J.H.C.
- C. roseus is known to be a plant hard to be artificially differentiated and no stable organ culture has been established yet, although reproduction of the whole plant, induction of a shoot tissue and its cultivation in a liquid medium have been reported.
- the induction of the shoot tissue mentioned above was made using callus and is far from a practical use for producing indole alkaloids because an induction frequency is very low and the induction from the callus takes a lot of time.
- an organ culture having high productivity of alkaloids is obtained by cultivating under light irradiation a seedling of C. roseus on a culture medium containing phytohormone, transferring branched tissue projected from a dicotyledonous portion of the seedling to the same culture medium, and cutivating said branched tissue.
- the alkaloids produced by the organ culture of the invention are composed of various indole alkaloids such as vinblastine, vincristine, vindoline, catharanthine, ajmalicine, and the like, which are all found in the parent plant.
- Vinblastine and vincristine are well known to be useful as antitumor agents.
- Vindoline and catharanthine are major alkaloids of C. roseus and are intermediate compounds of vinblastine and vincristine.
- Ajmalicine is converted, by oxidation, to serpentine which has hypotensive activity.
- Vindoline, catharanthine and ajmalicine are also useful as a hypoglycemic, diuretic or hypotensive agent.
- C. roseus indole alkaloids A mixture of these indole alkaloids will be referred to as "C. roseus indole alkaloids" hereinafter.
- the present invention provides a method for producing C. roseus indole alkaloids which comprises cultivating under light irradation a seedling of C. roseus on a culture medium containg phytohormone, transferring branched tissue projected from dicotyledonous portion of the seedling to the same culture medium, cultivating said branched tissue, and recovering alkaloids from the resultant organ culture.
- the invention also provides C. roseus indole alkaloids produced by the above process of the invention.
- the invention further provides an organ culture induced from C. roseus by the above-mentioned method, said culture being capable of producing substantial amounts of C. roseus indole alkaloids.
- Madagascar C. roseus is employed as a starting material.
- Seed of Madagascar C. roseus is sterilized on the surface, placed on sanitary cotton moistened with distilled water, or Murashige-Skoog medium, containing 0.55% by weight of agarose, and allowed to germinate under sterilized conditions.
- branched tissue After one or two weeks, projection of branched tissue is initiated at the dicotyledonous portion and a lot of shoots are developed.
- the developed shoots are cut off and subcultured on the same medium as above to obtain a stable organ culture.
- phytohormone such as benzyladenine is added to the medium at the concentration of 0.1-lOmg/litre, preferably, 1.Omg/litre.
- the induction of an organ culture can be achieved by direct cultivation of the seed in the medium supplemented by the phytohormone.
- subcultures can be carried out by either a surface or liquid culture.
- the shoot organ is transferred to, and cultivated in, a liquid medium of the same compositions as above or, where the shoot organ is cultivated on an agarose surface medium supplemented with benzyladenine and 0.01-l.Omg/litre of auxin, such as indoleacetic acid (IAA) or naphthaleneacetic acid (NAA), the growth of culture is accelerated 2 or 3 times as compared with the case where the surface medium supplemented with benzyladenine alone is employed. Such accelerated growth may be also attained by suitably adjusting medium compositions, cultivation temperature, intensity and duration of light irradiation.
- auxin such as indoleacetic acid (IAA) or naphthaleneacetic acid (NAA)
- the induction frequency of the organ culture of the invention is greater than 80% because the organ culture is directly induced from the seedling without passing a callus stage.
- the induction to a stable organ culture requires relatively short time, for instance, about 2 months from the germination.
- C. roseus alkaloids are found in every organ and tissue of the plant, the leaf has the highest contents of the alkaloids. Accordingly, the organ culture uniquely differentiated to a shoot organ may produce the alkaloids more efficiently than previously-known cell cultures.
- the shape and growth rate of the organ culture of the invention can be controlled by adjusting the amount of phytohormone to be added to the medium and/or culture conditions.
- a liquid culture is preferred because the growth rate of the liquid culture is several times greater than that of a surface culture and, therefore, the former is suitable for a mass production of the C. roseus alkaloids.
- the total alkaloids content in the dried organ culture of the present invention amounts to about 1/3 of that of the leaf tissue of the parent plant by weight/weight basis.
- vinblastine content in the dried organ culture is about 1/5 to 1/20 of that found in the leaf.
- the production efficiency of the alkaloids possessed by the organ culture is extremely higher than that of the parent plant.
- Recovery of the alkaloids from the shoot organ culture can be conducted in a conventional manner.
- the organ culture is lyophilized and extracted with methanol for 1 to 3 days. Evaporation to dryness of the resulting extract gives crude alkaloids as the residue.
- the residue containing the crude alkaloids is dissloved in a phosphate buffer (pH 7.4) and employed as a sample for a radioimmunoassay described hereinafter.
- the alkaloids content of a callus culture is relatively low.
- the maximum of vinblastine content found in our experiments is 10 ⁇ g/g (dired callus weight).
- repeated subculture of the callus leads to a rapid decrease of the alkaloids content.
- no alkaloid is found in a callus which has been subcultured over several months.
- the organ culture of the invention has a high content of alkaloids as illustrated in the following Example, wherein vinblastine content of 90ug/g (dried tissue weight) was obtained from the initial organ culture.
- the culture of the invention also retains its shape and alkaloids content during repeated subcultures. Accordingly, the organ culture of the invention provides a means affording various alkaloids useful as an antitumor, hypotensive, antiarrhythmic agent, or the like.
- a seed of Madagascar C. roseus was sterilized on the surface by the use of 1% NaOCI and allowed to germinate on sanitary cotton moistened with water to obtain the seedling.
- the seedling was transferred to Murashige-skoog medium containing 0.55% by weight of agarose and cultivated at 25°C under irradiation of monolux light (about 1000 lux).
- the seedling did not grow normally and, a lot of branched tissues were developed and projected at the dicotyledonous portion of the seedling.
- the branched tissues were cut off and cultivated under the same conditions mentioned above. The branched tissues grew actively to give a stable shoot organ culture and gained 10 times weight of the initial weight in one month cutivation.
- Vinblastine content of the organ culture obtained above and the parent plant were determined by radioimmunoassay in a conventional manner. The result is shown in Table 1.
- indole alkaloids than vinblastine contained in the organ culture i.e., vindoline, catharanthine and ajmalicine were assayed in the following manner.
- TLC thin layer chromatograghy
- Kieselgel 60 F 254 Merk
- ethyl acetate : ethanol (1:1) a developing solvent
- Detection of alkaloids on TLC was carried out by U.V. light irradiation, or by spraying ceric ammonium sulfate solution, and particular alkaloid was identified on the basis of Rf value comparing with that of an authentic sample.
- the HPLC and TLC analysis revealed that vindoline, catharanthine and ajmalicine contents in the organ culture of the invention are respectively about 12 mg, 3 mg and 0.3 mg/g dry weight of the organ.
- the vindoline content was found to be substantially the same as that of the parent plant, while catharanthine content was about 10 times higher than that of the plant, and ajmalcine content was about 1/10 to 1/50 of the plant.
- the total alkalioids produced by the organ culture of the invetion were assayed by "methyl orange" method (see A.O. Gettler and I.Sunshine, Anal. Chem., 23, 779-781 (1951)).
- the total alkaloids content was 0.2 % on the basis of dry weight of the the organ culture which corresponds to 1/3 of that of the parent plant.
- the total alkaloids are supposed to include vincristine together with aforementioned alkaloids.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60095756A JPS61254127A (ja) | 1985-05-02 | 1985-05-02 | ニチニチソウ器官培養によるインド−ルアルカロイドの製造方法 |
| JP95756/85 | 1985-05-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0200225A2 true EP0200225A2 (fr) | 1986-11-05 |
| EP0200225A3 EP0200225A3 (fr) | 1989-02-22 |
Family
ID=14146337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP86105971A Withdrawn EP0200225A3 (fr) | 1985-05-02 | 1986-04-30 | Culture d'un organe de catharanthus roseus capable de produire une quantité considérable d'alcaloides indoliques |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4910138A (fr) |
| EP (1) | EP0200225A3 (fr) |
| JP (1) | JPS61254127A (fr) |
| AU (1) | AU5683586A (fr) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993000424A1 (fr) * | 1991-06-21 | 1993-01-07 | Worcester Polytechnic Institute | Procede pour extraire des quantites accrues de metabolites secondaires de plantes avec perte limitee de la viabilite de la plante |
| WO1995019698A1 (fr) * | 1994-01-21 | 1995-07-27 | Goldsmith Seeds Inc. | Gene de catharantus resistant au phytophthora et son utilisation |
| CN102613088A (zh) * | 2012-04-23 | 2012-08-01 | 上海安体康生植物化学有限公司 | 培育耐盐耐低温长春花株系快速繁殖的方法 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02138984A (ja) * | 1987-03-10 | 1990-05-28 | Kao Corp | ビスベンジルイソキノリンアルカロイドの製造法及びそれに用いる培地 |
| ATE91710T1 (de) * | 1988-09-19 | 1993-08-15 | Nestle Sa | Verfahren zur produktion von pflanzensubstanzen. |
| US5019504A (en) * | 1989-03-23 | 1991-05-28 | The United States Of America As Represented By The Secretary Of Agriculture | Production of taxol or taxol-like compounds in cell culture |
| US5344775A (en) * | 1991-11-15 | 1994-09-06 | Escagenetics Corporation | Synthesis of taxanes in culture using pseudocalluscells |
| CA2434692A1 (fr) * | 1992-04-07 | 1993-10-08 | Paul M. Cino | Induction de cellules de cal et la preparation de taxanes |
| US5753507A (en) * | 1995-09-22 | 1998-05-19 | Novartis Finance Corporation | Plant geraniol/nerol 10-hydroxylase and DNA coding therefor |
| WO2006113382A2 (fr) | 2005-04-15 | 2006-10-26 | Wake Forest University Health Sciences | Systeme de bioreacteur et procede destine a ameliorer la fonctionnalite du muscle cultive in vitro |
| AU2011289214B2 (en) | 2010-08-13 | 2015-05-28 | Wake Forest University Health Sciences | Methods for making a tissue engineered muscle repair (TEMR) construct in vitro for implantation in vivo |
| CN105254651A (zh) * | 2015-09-27 | 2016-01-20 | 常州市奥普泰科光电有限公司 | 一种从培育长春花中提取高纯度长春新碱的方法 |
| CN114574516B (zh) * | 2022-01-18 | 2023-10-27 | 浙江大学杭州国际科创中心 | 一种基于CRISPR/Cas9的酵母基因组稳定整合方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3097137A (en) * | 1960-05-19 | 1963-07-09 | Canadian Patents Dev | Vincaleukoblastine |
| US3225030A (en) * | 1965-02-15 | 1965-12-21 | Lilly Co Eli | Method of preparing leurosine and vincaleukoblastine |
| HU183978B (en) * | 1982-06-28 | 1984-06-28 | Gyogyszerkutato Intezet | Process for preparing the propagative material of plants in tissue culture |
-
1985
- 1985-05-02 JP JP60095756A patent/JPS61254127A/ja active Pending
-
1986
- 1986-04-30 AU AU56835/86A patent/AU5683586A/en not_active Abandoned
- 1986-04-30 EP EP86105971A patent/EP0200225A3/fr not_active Withdrawn
- 1986-05-01 US US06/858,122 patent/US4910138A/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| BIOTECHNOLOGY AND BIOENGINEERING, vol. 24, 1982, pages 1965-1974, John Wiley & Sons, Inc., New York, US; B.DEUS et al.: "Exploitation of plant cells for the production of natural compounds" * |
| CHEMICAL ABSTRACTS, vol. 87, no. 19, 7th November 1977, page 143, no. 146887n, Columbus, Ohio, US; B.DHRUVA et al.: "Studies in Catharanthus roseus callus cultures, callus initiation and differentiation" & CURR. SCI. 1977, 46(11), 364-5 * |
| PLANT PHYSIOLOGY, vol. 75, suppl. 1, 1984, page 145, Bethesda, US; B.G.MERSEY et al.: "Differentiation of "Alkaloid Cells" in Catharanthus roseus leaves" * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993000424A1 (fr) * | 1991-06-21 | 1993-01-07 | Worcester Polytechnic Institute | Procede pour extraire des quantites accrues de metabolites secondaires de plantes avec perte limitee de la viabilite de la plante |
| US5413928A (en) * | 1991-06-21 | 1995-05-09 | Worcester Polytechnic Institute | Process for extracting enhanced amounts of plant secondary metabolites with limited loss of plant viability |
| WO1995019698A1 (fr) * | 1994-01-21 | 1995-07-27 | Goldsmith Seeds Inc. | Gene de catharantus resistant au phytophthora et son utilisation |
| CN102613088A (zh) * | 2012-04-23 | 2012-08-01 | 上海安体康生植物化学有限公司 | 培育耐盐耐低温长春花株系快速繁殖的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| US4910138A (en) | 1990-03-20 |
| AU5683586A (en) | 1986-11-06 |
| EP0200225A3 (fr) | 1989-02-22 |
| JPS61254127A (ja) | 1986-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cheng | Adventitious bud formation in culture of Douglas fir (Pseudotsuga menziesii (Mirb.) Franco) | |
| Tabata et al. | Variation of alkaloid production in Nicotiana rustica callus cultures | |
| Endo et al. | Alkaloid production in root and shoot cultures of Catharanthus roseus | |
| US4910138A (en) | Use of an organ culture of Catharanthus roseus to produce vincristine and vinblastine | |
| US4241536A (en) | Embryogenesis in vitro, induction of qualitative and quantitative changes in metabolites produced by plants and products thereof | |
| Rehman et al. | In vitro regeneration of witloof chicory (Cichorium intybus L.) from leaf explants and accumulation of esculin | |
| Anderson et al. | Alkaloid production by leaf organ, root organ and cell suspension cultures of Cinchona ledgeriana | |
| Etienne et al. | Relations between exogenous growth regulators and endogenous indole-3-acetic acid and abscisic acid in the expression of somatic embryogenesis in Hevea brasiliensis (Müll. Arg.) | |
| Pietrosiuk et al. | Catharanthus roseus: micropropagation and in vitro techniques | |
| Staba et al. | Alkaloid production from Papaver tissue cultures | |
| Fulzele et al. | Somatic embryogenesis, plant regeneration, and the evaluation of camptothecin content in Nothapodytes foetida | |
| Nikam et al. | Multiple shoot regeneration and alkaloid cerpegin accumulation in callus culture of Ceropegia juncea Roxb. | |
| US5344775A (en) | Synthesis of taxanes in culture using pseudocalluscells | |
| Biesboer et al. | The effect of medium modification and selected precursors on sterol production by short-term callus cultures of Euphorbia tirucalli | |
| SAITO et al. | Lupin Alkaloids in Tissue Culture of Sophora flavescens car. angustifolia: Greening Induced Production of Matrine | |
| Bajaj et al. | A tropa belladonna L.: In Vitro Culture, Regeneration of Plants, Cryopreservation, and the Production of Tropane Alkaloids | |
| Hiraoka et al. | Alkaloid production by somatic embryo cultures of Corydalis ambigua | |
| Morris | Regulation of Product Synthesis in Cell Cultures of Catharanthus roseus. III. Alkaloid Metabolism in Cultured Leaf Tissue and Primary Callus1 | |
| Furuya et al. | Alkaloid production in cultured cells of Dioscoreophyllum cumminsii | |
| WO1993002204A1 (fr) | Production de ginkgolides en culture cellulaire | |
| Choi et al. | Saponin production in tissue culture of ginseng (Panax ginseng CA Meyer) | |
| Hsu et al. | Metabolism of 14C-codeine in cell cultures of Papaver somniferum | |
| Kamo et al. | Morphinan alkaloids: biosynthesis in plant (Papaver spp.) tissue cultures | |
| Filippini et al. | Somatic embryogenesis and indole alkaloid production in Catharanthus roseus | |
| El Badaoui et al. | Production of solamargine by in vitro cultures of Solanum paludosum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): CH DE FR GB IT LI NL SE |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): CH DE FR GB IT LI NL SE |
|
| 17P | Request for examination filed |
Effective date: 19890816 |
|
| 17Q | First examination report despatched |
Effective date: 19910122 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19910604 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MIURA, YOSHIHARU Inventor name: HIRATA, KAZUMASA |